Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane

Clinical trial NCT03930680 · COMPLETED

Trial details

NCT number: NCT03930680
Sponsor: University of Arkansas
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Degradation of Top2b and Top2a in Human by Dexrazoxane Time Course and Degradation of Top2b in Human by Dexrazoxane Effects of Dexrazoxane on Healthy Human

Start date: 2021-09-14
Primary completion: 2024-06-11
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.